The use of newer progestins for contraception
review
OA: closed
CC0
⤵ 18 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This review discusses the efficacy, safety, and user acceptability of newer progestins in combined oral contraceptives and progestin-only methods for women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (90)
- Comparative Pharmacology of Newer Progestogens via openalex
- Effect of dienogest-containing oral contraceptives on lipid metabolism via openalex
- Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters via openalex
- Estradiol Valerate/Dienogest via openalex
- New progestagens for contraceptive use via openalex
- [Nomegestrol acetate: clinical pharmacology]. via openalex
- Pharmacological profile of progestins via openalex
- Pharmacology of estradiol valerate/dienogest. via openalex
- Progestins and Antiprogestins in Clinical Practice via openalex
- Reprint of Classification and pharmacology of progestins via openalex
- Reprint of Pharmacological profile of progestins via openalex
- doi:10.1016/j.contraception.2006.07.013 via openalex
- doi:10.1097/aog.0b013e3181b46f54 via openalex
- doi:10.1023/a:1020072325818 via openalex
- doi:10.1080/09513590701267727 via openalex
- doi:10.1016/s0039-128x(00)00119-7 via openalex
- doi:10.1016/0010-7824(90)90062-z via openalex
- doi:10.1016/j.contraception.2009.01.005 via openalex
- doi:10.1016/s0039-128x(03)00140-5 via openalex
- doi:10.1016/j.ajog.2005.12.007 via openalex
- doi:10.1007/s00404-008-0907-x via openalex
- doi:10.1016/s0960-9776(03)00003-1 via openalex
- doi:10.1080/09513590701585003 via openalex
- doi:10.1136/bmj.c927 via openalex
- doi:10.1136/bmj.b2890 via openalex
- doi:10.1016/j.maturitas.2004.06.007 via openalex
- doi:10.3109/09513599909167574 via openalex
- W2149306052 via openalex
- doi:10.1016/j.ejogrb.2005.12.004 via openalex
- doi:10.1016/0010-7824(93)90112-k via openalex
- doi:10.1016/j.ajog.2004.01.056 via openalex
- doi:10.1016/j.contraception.2004.08.010 via openalex
- doi:10.1056/nejmoa013202 via openalex
- doi:10.1016/j.contraception.2005.09.015 via openalex
- doi:10.1210/endo.143.1.8582 via openalex
- doi:10.1097/01.gme.0000230348.05745.7d via openalex
- doi:10.1016/0960-0760(95)00171-u via openalex
- doi:10.1111/j.1472-8206.1987.tb00562.x via openalex
- doi:10.1016/s0378-5173(00)00357-4 via openalex
- doi:10.1186/1471-2407-8-166 via openalex
- doi:10.1016/0010-7824(93)90117-p via openalex
- doi:10.1210/jc.2007-0026 via openalex
- doi:10.1016/j.jsbmb.2009.04.004 via openalex
- doi:10.1016/0010-7824(91)90080-y via openalex
- doi:10.1124/mol.108.054312 via openalex
- doi:10.1097/00006250-200304000-00031 via openalex
- doi:10.1016/s0015-0282(16)58204-1 via openalex
- doi:10.1210/en.143.1.205 via openalex
- doi:10.1080/13697130802403994 via openalex
- doi:10.1016/s1090-798x(10)79320-6 via openalex
- W2165569865 via openalex
- W2231044614 via openalex
- W2414127269 via openalex
- W2797816625 via openalex
- W6605736569 via openalex
- W6657148280 via openalex
- W6684190924 via openalex
- W6689571879 via openalex
- W6715887453 via openalex
- doi:10.1016/j.jsbmb.2005.06.032 via openalex
- doi:10.1016/0010-7824(94)00006-i via openalex
- doi:10.1160/th07-12-0746 via openalex
- doi:10.1080/13697130500330341 via openalex
- doi:10.1016/j.maturitas.2003.09.014 via openalex
- doi:10.1016/s0010-7824(96)00195-3 via openalex
- doi:10.1016/j.contraception.2007.08.006 via openalex
- doi:10.1016/s0010-7824(01)00259-1 via openalex
- doi:10.1111/j.1538-7836.2008.02863.x via openalex
- doi:10.1016/j.maturitas.2008.10.017 via openalex
- doi:10.1111/j.1538-7836.2007.02863.x via openalex
- doi:10.1111/j.1524-4741.2008.00621.x via openalex
- doi:10.1080/09513590701325731 via openalex
- doi:10.1016/j.contraception.2003.08.014 via openalex
- doi:10.1016/s0010-7824(00)00133-5 via openalex
- doi:10.1016/s0039-128x(00)00120-3 via openalex
- doi:10.1016/0010-7824(90)90082-7 via openalex
- doi:10.1517/14656566.8.7.989 via openalex
- doi:10.1080/13697130601114859 via openalex
- doi:10.1161/circulationaha.104.501502 via openalex
- doi:10.1016/j.jsbmb.2008.02.002 via openalex
- doi:10.1016/s0039-128x(03)00142-9 via openalex
- doi:10.1136/bmj.b2921 via openalex
- doi:10.1016/j.contraception.2006.12.019 via openalex
- doi:10.1073/pnas.122225699 via openalex
- W141531064 via openalex
- doi:10.1016/j.maturitas.2009.01.004 via openalex
- doi:10.1016/j.steroids.2003.08.008 via openalex
- doi:10.1158/1055-9965.epi-08-0056 via openalex
- doi:10.1016/j.maturitas.2006.07.003 via openalex
- doi:10.1111/j.1471-0528.1987.tb02322.x via openalex
Cited by (18)
- Ovulation: A consequence of acute inflammation cultivated by E2-induced reactive oxygen species and triggered by progesterone withdrawal 2025
- Efficiency of using dienogest at the stage of pregravid preparation on the course of pregnancy and the outcome of childbirth in patients with endometriosis 2024
- Short-term Efficacy of Dienogest in Improving Pain in Patients with Endometriosis: A Single-center Experience 2021
- Comparison of effect of preoperative dienogest and gonadotropin-releasing hormone agonist administration on laparoscopic cystectomy for ovarian endometriomas 2020
- Effects of new generation progestins, including as mixtures and in combination with other classes of steroid hormones, on zebrafish early life stages 2019
- Modern trends in the treatment of endometriosis 2019
- <p>Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain</p> 2019
- Use of Dienogest or Gonadotropin Releasing Hormone Agonist with Add back Hormone Therapy in Longterm Endometriosis Medical Management 2018
- Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age 2018
- Progesterone resistance in endometriosis: origins, consequences and interventions 2017
- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy 2017
- The possibility of treatment with dienogest 2 mg in patients with genital endometriosis 2017
- Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive 2016
- Retrospective Review of Norethindrone Use in Adolescents 2013
- Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM) 2013
- Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study 2013
- Special biological issues in the management of women with schizophrenia 2012
- Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive 2011
Source provenance
- openalex
- last seen: 2026-05-14T06:05:56.263833+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK